A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up

Recruiting

• Conditions: Interstitial Lung Disease

• Registration Number: NCT05810493
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

The purpose of the study is to conduct a descriptive analysis of the population of patients with an interstitial lung disease received in the pulmonary department of University hospital of Nice (France). Analysis and documentation of clinical forms of the disease, therapeutics used and evolutions.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-01
• Status Verified: 2023-03
• Study First Submitted: 2023-03-29
• Study First Submitted QC: 2023-04-11
• Study First Posted: 2023-04-12
• Last Update Submitted: 2023-05-09
• Last Update Posted: 2023-05-10
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

• Age ≥ 18 years old
• Diagnosis of interstitial lung disease according to the multidisciplinary monthly meeting for interstitial lung disease occuring at University hospital of Nice, France

Exclusion Criteria

• Patient-led opposition to data collection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Build a retrospective cohort of patients with phenotyped interstitial Lung disease with longitudinal follow-up	2 years

Secondary Outcome Measures

Name	Time	Method
Follow-up of progression criteria according to diagnosis	2 years	Impact of interstitial lung disease treatements

Trial Locations

Locations (1)

University Hospital of Nice; 🇫🇷 Nice, France